Hyperbaric Oxygen Therapy for COVID-19 Patients: A Prospective, Randomized Controlled Trial

Autor: Shai Efrati, Korin C, Yair Bechor, Hamed Ra, Korach Ol, Irma Tzur, Shiloah E, Wang Z, Adler-Vallach K, Amir Hadanny, Zemel Y, Yonatan Shapira, Finci S, Gabriella L, Oleg Gorelik, Naomi Rahimi-Levene, Catalogna M, Eduard Ilgiyaev, Mizrachi A, Maor Y, Lang E, Hamad M, Tarasula N

Publikováno v: SSRN Electronic Journal.

Introduction: The hallmarks of pulmonary derangement due to severe COVID-19 disease include hypoxemia and a dysregulated and excessive immune response, i.e. a "cytokine storm". Several case series reported on the beneficial effect of hyperbaric oxyge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::44ad4c018bab1e1ed350357227a59a26
https://doi.org/10.2139/ssrn.3745115

Combination Anticancer Therapies Using Selected Phytochemicals.

Autor: Talib WH; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931-166, Jordan., Awajan D; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931-166, Jordan., Hamed RA; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931-166, Jordan., Azzam AO; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931-166, Jordan., Mahmod AI; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931-166, Jordan., Al-Yasari IH; Department of Genetic Engineering, College of Biotechnology, Al-Qasim Green University, Babylon 964, Iraq.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2022 Aug 25; Vol. 27 (17). Date of Electronic Publication: 2022 Aug 25.

Plants as a Source of Anticancer Agents: From Bench to Bedside.

Autor: Talib WH; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931, Jordan., Daoud S; Department Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan., Mahmod AI; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931, Jordan., Hamed RA; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931, Jordan., Awajan D; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931, Jordan., Abuarab SF; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931, Jordan., Odeh LH; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931, Jordan., Khater S; Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931, Jordan., Al Kury LT; Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2022 Jul 27; Vol. 27 (15). Date of Electronic Publication: 2022 Jul 27.

Inoperable de novo metastatic colorectal cancer with primary tumour in situ : Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre).

Autor: Hamed RA; Department of Oncology, Mid-Western Cancer Centre, University Hospital Limerick, Limerick V94 F858, Ireland., Marks S; Department of Oncology, Mid-Western Cancer Centre, University Hospital Limerick, Limerick V94 F858, Ireland., Mcelligott H; Department of Oncology, Mid-Western Cancer Centre, University Hospital Limerick, Limerick V94 F858, Ireland., Kalachand R; Department of Oncology, Mid-Western Cancer Centre, University Hospital Limerick, Limerick V94 F858, Ireland., Ibrahim H; Palliative Department, St. Francis Hospice, Dublin 5 D05 T9K8, Ireland., Atyani S; Radiology Department, University Hospital Limerick, Limerick V94 F858, Ireland., Korpanty G; Department of Oncology, Mid-Western Cancer Centre, University Hospital Limerick, Limerick V94 F858, Ireland., Osman N; Department of Oncology, Mid-Western Cancer Centre, University Hospital Limerick, Limerick V94 F858, Ireland.

Publikováno v: Molecular and clinical oncology [Mol Clin Oncol] 2022 Feb; Vol. 16 (2), pp. 40. Date of Electronic Publication: 2021 Dec 21.

Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies.

Autor: Mohty R; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Dulery R; Department of Hematology, Saint Antoine Hospital, AP-HP, Paris, France.; Sorbonne University, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France., Bazarbachi AH; Department of Internal Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY, USA., Savani M; Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA., Hamed RA; Department of Internal Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY, USA., Bazarbachi A; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Mohty M; Department of Hematology, Saint Antoine Hospital, AP-HP, Paris, France. mohamad.mohty@inserm.fr.; Sorbonne University, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France. mohamad.mohty@inserm.fr.

Publikováno v: Blood cancer journal [Blood Cancer J] 2021 Jul 09; Vol. 11 (7), pp. 126. Date of Electronic Publication: 2021 Jul 09.